Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LATS1 | O95835 | 4/20 | 0.41 |
| ▸ | LATS2 | Q9NRM7 | 1/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 8/20 | 0.37 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.37 |
| ▸ | PIP4K2A | P48426 | 2/20 | 0.36 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.35 |
| ▸ | IGLV6-57 | P01721 | 1/20 | 0.35 |
| ▸ | USP7 | Q93009 | 1/20 | 0.35 |
| ▸ | DHODH | Q02127 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CCR5 | P51681 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17503833 | 0.86 | LATS1 (0.40) | LATS1LATS2KDM4CNOX1PIP4K2A | |
| SCHEMBL19158281 | 0.77 | KDM4C (0.51) | LATS1LATS2KDM4CPIP4K2A | |
| SCHEMBL19158357 | 0.76 | KDM4C (0.40) | LATS1LATS2KDM4CNOX1PIP4K2A | |
| SCHEMBL19158870 | 0.76 | LATS1 (0.41) | LATS1LATS2KDM4CUSP7DHODH | |
| SCHEMBL19158774 | 0.74 | KDM4C (0.39) | LATS1LATS2KDM4C | |
| SCHEMBL19159348 | 0.72 | ALDH1A1 (0.41) | LATS1LATS2KDM4C | |
| SCHEMBL19158161 | 0.70 | HRH3 (0.45) | LATS1LATS2KDM4C | |
| SCHEMBL17503666 | 0.69 | KDM4C (0.42) | LATS1LATS2KDM4C | |
| SCHEMBL19159350 | 0.67 | LATS1 (0.45) | LATS1LATS2KDM4C | |
| SCHEMBL17503801 | 0.67 | KDM4C (0.39) | LATS1LATS2KDM4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970211-B1 | HISTONE DEMETHYLASE INHIBITORS | QUANTICEL PHARMACEUTICALS INC (US) | 2017-07-26 | — | — | EP | disclosed |